XML 15 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK-BASED COMPENSATION
12 Months Ended
Oct. 31, 2013
STOCK-BASED COMPENSATION [Abstract]  
STOCK-BASED COMPENSATION
  9. STOCK-BASED COMPENSATION

 

In March 2008, we adopted the Hurco Companies, Inc. 2008 Equity Incentive Plan (the "2008 Plan"), which allows us to grant awards of stock options, Stock Appreciation Rights settled in stock (SARs), restricted shares, performance shares and performance units. The 2008 Plan replaced the 1997 Stock Option and Incentive Plan, which expired in March 2007. The Compensation Committee of the Board of Directors has authority to determine the officers, directors and key employees who will be granted awards; designate the number of shares subject to each award; determine the terms and conditions upon which awards will be granted; and prescribe the form and terms of award agreements. We have granted stock options under both plans which are currently outstanding and restricted shares under the 2008 Plan. No stock option may be exercised more than ten years after the date of grant or such shorter period as the Compensation Committee may determine at the date of grant. The total number of shares of our common stock that may be issued as awards under the 2008 Plan is 750,000. The market value of a share of our common stock, for purposes of the 2008 Plan, is the closing sale price as reported by the Nasdaq Global Select Market on the date in question or, if not a trading day, on the last preceding trading date.

 

During fiscal 2013, 2012 and 2011, we recorded approximately $979,000, $870,000 and $470,000, respectively, of stock-based compensation expense related to grants under the plans. As of October 31, 2013, there was approximately $896,000 of total unrecognized stock-based compensation cost that we expect to recognize by the end of the first quarter of fiscal 2016.

 

During fiscal 2013, options to purchase 11,369 shares were exercised, resulting in cash proceeds of approximately $303,000.

 

On March 14, 2013, the Compensation Committee granted a total of 6,230 shares of restricted stock to our non-employee directors. The restricted stock vests in full one year from the date of grant provided the recipient remains on the board of directors through that date. The grant date fair value of the restricted stock is based on the closing sales price of our common stock on the grant date which was $28.08 per share.

 

On December 12, 2012, the Compensation Committee granted a total of 24,976 stock options under the 2008 Plan to our executive officers. The fair value of the options was estimated on the date of grant using a Black-Scholes valuation model with assumptions for expected volatility based on the historical volatility of our common stock of 62%, expected term of the options of five years, dividend yield rate of 0% and a risk-free interest rate of .66% based upon the five-year U.S. Treasury yield as of the date of grant. The options vest over a three-year period beginning one year from the date of grant. Based upon the foregoing factors, the grant date fair value of the stock options was determined to be $12.11 per share.

 

On December 12, 2012, the Compensation Committee granted a total of 12,983 shares of restricted stock to our executive officers. The restricted stock vests in full three years from the date of grant provided the recipient remains employed by us through that date. The grant date fair value of the restricted stock is based on the closing sales price of our common stock on the grant date which was $23.30 per share.

 

On March 15, 2012, the Compensation Committee granted a total of 6,475 shares of restricted stock to our non-employee directors. The restricted stock vests in full one year from the date of grant provided the recipient remains on the board of directors through that date. The grant date fair value of the restricted stock is based on the closing sales price of our common stock on the grant date which was $27.00 per share.

 

On December 14, 2011, the Compensation Committee granted a total of 45,236 stock options under the 2008 Plan to our executive officers. The fair value of the options was estimated on the date of grant using a Black-Scholes valuation model with assumptions for expected volatility based on the historical volatility of our common stock of 64%, expected term of the options of five years, dividend yield rate of 0% and a risk-free interest rate of .86% based upon the five-year U.S. Treasury yield as of the date of grant. The options vest over a three-year period beginning one year from the date of grant. Based upon the foregoing factors, the grant date fair value of the stock options was determined to be $11.50 per share.

 

On December 14, 2011, the Compensation Committee granted a total of 24,243 shares of restricted stock to our executive officers. The restricted stock vests in full three years from the date of grant provided the recipient remains employed by us through that date. The grant date fair value of the restricted stock is based on the closing sales price of our common stock on the grant date which was $21.45 per share.

 

During fiscal 2012, options to purchase 500 shares were exercised, resulting in cash proceeds of approximately $1,000.

 

On March 17, 2011, the Compensation Committee granted a total of 5,859 shares of restricted stock under the 2008 Plan to our non-employee directors. The restricted stock vests one year from the date of grant provided the recipient remains on the board of directors through that date. The grant date fair value of the restricted stock is based on the closing sales price of our common stock on the grant date which was $29.86 per share.

 

On December 22, 2010, the Compensation Committee granted a total of 25,000 shares of restricted stock under the 2008 Plan to our executive officers. The restricted stock vests in full three years from the date of grant provided the recipient remains employed by us through that date. The grant date fair value of the restricted stock is based on the closing sales price of our common stock on the grant date which was $23.10 per share.

 

A reconciliation of the Company's restricted stock activity and related information is as follows:

 

    Number of
Shares
    Weighted Average
Grant Date
Fair Value
 
Unvested at October 31, 2012     55,718     $ 22.84  
Shares granted     19,213       24.85  
Shares vested     (6,475 )     27.00  
Shares cancelled     -       -  
Unvested at October 31, 2013     68,456     $ 23.01  
                 

 

A summary of the status of the options as of October 31, 2013, 2012 and 2011 and the related activity for the year is as follows:

 

    Shares Under
Option
    Weighted Average
Exercise Price Per Share
 
Balance October 31, 2010     115,369     $ 20.66  
Granted     -       -  
Cancelled     -       -  
Expired     -       -  
Exercised     -       -  
Balance October 31, 2011     115,369     $ 20.66  
Granted     45,236       21.45  
Cancelled     (5,000 )     26.69  
Expired     -       -  
Exercised     (500 )     2.15  
Balance October 31, 2012     155,105     $ 20.75  
Granted     24,976       23.30  
Cancelled     -       -  
Expired     -       -  
Exercised     (11,369 )     26.69  
Balance October 31, 2013     168,712     $ 20.73  

 

The total intrinsic value of stock options exercised during the twelve months ended October 31, 2013, 2012 and 2011 was approximately $0, $10,000 and $0, respectively.

 

As of October 31, 2013, the total intrinsic value of outstanding stock options already vested and expected to vest and the intrinsic value of options that are outstanding and exercisable was $786,000. Stock options outstanding and exercisable on October 31, 2013, are as follows:

 

Range of Exercise
Prices Per Share
    Shares Under
Option
    Weighted Average
Exercise Price Per
Share
    Weighted Average
Remaining Contractual
Life in Years
 
Outstanding                          
$ 14.82       30,000     $ 14.82       6.1  
  14.88       21,000       14.88       5.5  
  18.13       20,000       18.13       6.5  
  21.45       45,236       21.45       8.1  
  23.30       24,976       23.30       9.1  
  26.69       17,500       26.69       3.0  
  35.83       10,000       35.83       4.6  
$ 14.82 - 35.83       168,712     $ 20.73       6.7  
Exercisable                          
$ 14.82       30,000     $ 14.82       6.1  
  14.88       14,000       14.88       3.6  
  18.13       20,000       18.13       6.5  
  21.45       15,079       21.45       2.7  
  26.69       17,500       26.69       3.0  
  35.83       10,000       35.83       4.6  
$ 14.82 - 35.83       106,579     $ 20.31       4.7